146 related articles for article (PubMed ID: 30324788)
1. Autoimmune Neurological Disorder with Anti-Ma2/Ta Antibodies in a Pediatric Patient.
Boniel S; Jeziorek A; Woźniak M; Lipińska E; Szczepanik E; Demkow U; Szymańska K
Isr Med Assoc J; 2018 Oct; 20(10):653-655. PubMed ID: 30324788
[No Abstract] [Full Text] [Related]
2. Paraneoplastic opsoclonus and cerebellar ataxia related to anti-Ma2 antibody: a case report.
Mélé N; Hautefort C; Toledano A; Delattre JY; Psimaras D
J Neurol; 2016 Feb; 263(2):405-406. PubMed ID: 26754007
[No Abstract] [Full Text] [Related]
3. [A case of an anti-Ma2 antibody-positive patient presenting with variable CNS symptoms mimicking multiple system atrophy with a partial response to immunotherapy].
Shiraishi W; Iwanaga Y; Yamamoto A
Rinsho Shinkeigaku; 2015; 55(2):96-100. PubMed ID: 25746072
[TBL] [Abstract][Full Text] [Related]
4. Morvan syndrome associated with CASPR2 and LGI1 antibodies in a child.
Nikolaus M; Jackowski-Dohrmann S; Prüss H; Schuelke M; Knierim E
Neurology; 2018 Jan; 90(4):183-185. PubMed ID: 29263225
[No Abstract] [Full Text] [Related]
5. New autoantibodies in pediatric opsoclonus myoclonus syndrome.
Kirsten A; Beck S; Fühlhuber V; Kaps M; Kreutz T; Korfei M; Schmitt S; Preissner KT; Blaes F
Ann N Y Acad Sci; 2007 Sep; 1110():256-60. PubMed ID: 17911440
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplastic neurological syndrome associated with anti-Ma2 antibodies].
Khammassi N; Balhouane I; Gargouri A; Gouider R; Cherif O
Rev Neurol (Paris); 2012 Feb; 168(2):192-3. PubMed ID: 21962240
[No Abstract] [Full Text] [Related]
7. Paraneoplastic Neurological Syndromes: A Condition of Increasing Recognition.
Seluk L; Kivity S
Isr Med Assoc J; 2018 Oct; 20(10):649-650. PubMed ID: 30324785
[No Abstract] [Full Text] [Related]
8. Anti-Ma2/Ta antibodies in a woman with primary lateral sclerosis-like phenotype and Sjögren syndrome.
Piccolo G; Tavazzi E; Jarius S; Alfonsi E; Cavagna L; Piccolo L; Zardini E; Voltz R; Franciotta D
Neurol Sci; 2011 Oct; 32(5):915-7. PubMed ID: 21369848
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.
Bradwell AR
Clin Rev Allergy Immunol; 2000 Aug; 19(1):19-29. PubMed ID: 11064823
[No Abstract] [Full Text] [Related]
10. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
Blaes F; Dharmalingam B
Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
[TBL] [Abstract][Full Text] [Related]
11. Opsoclonus, limbic encephalitis, anti-Ma2 antibodies and gastric adenocarcinoma.
Biotti D; Viaccoz A; Olivier N; Tilikete C; Rogemond V; Honnorat J; Vighetto A
Eur J Neurol; 2012 Dec; 19(12):e144-5. PubMed ID: 23157246
[No Abstract] [Full Text] [Related]
12. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS).
Krasenbrink I; Fühlhuber V; Juhasz-Boess I; Stolz E; Hahn A; Kaps M; Hero B; Blaes F
Neuropediatrics; 2007 Jun; 38(3):114-6. PubMed ID: 17985258
[TBL] [Abstract][Full Text] [Related]
13. Lateral medullary syndrome with anti-neuronal antibodies (anti-Ta/Ma2) in primary Sjogren's syndrome.
Mehta P; Fernando MM; Pickering MC; Wilson Y; Molloy S; Colaco CB
Rheumatology (Oxford); 2009 Sep; 48(9):1174-6. PubMed ID: 19620208
[No Abstract] [Full Text] [Related]
14. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
Yamamoto T; Tsuji S
Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
[TBL] [Abstract][Full Text] [Related]
15. [Paraneoplastic opsoclonus-myoclonus syndrome (POMS)].
Matsumoto H; Ugawa Y
Nihon Rinsho; 2015 Sep; 73 Suppl 7():763-7. PubMed ID: 26480791
[No Abstract] [Full Text] [Related]
16. [Autoantibodies in Paraneoplastic Neurological Syndrome].
Kawachi I
Brain Nerve; 2018 Apr; 70(4):329-339. PubMed ID: 29632281
[TBL] [Abstract][Full Text] [Related]
17. Opsoclonus in Anti-Ma2 Brain-Stem Encephalitis.
Kunchok A; McKeon A
N Engl J Med; 2020 Sep; 383(13):e84. PubMed ID: 32966725
[No Abstract] [Full Text] [Related]
18. IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome.
Beck S; Fühlhuber V; Krasenbrink I; Tschernatsch M; Kneifel N; Kirsten A; Jaeger C; Kaps M; Preissner KT; Lang B; Rostasy K; Blaes F
J Neuroimmunol; 2007 Apr; 185(1-2):145-9. PubMed ID: 17324472
[TBL] [Abstract][Full Text] [Related]
19. Overinterpretation and Overtreatment of Low-Titer Antibodies Against Contactin-Associated Protein-2.
Bien CG
Front Immunol; 2018; 9():703. PubMed ID: 29696018
[TBL] [Abstract][Full Text] [Related]
20. Ma2 antibody-associated limbic encephalitis: The early etiology treatment may modify the disease clinical trajectory.
Mattioli P; Grisanti S; Massa F; Morbelli S; Boni S; Beronio A; Rebella G; Roccatagliata L; Nobili L; Franciotta D; Micalizzi E; Nobili F; Arnaldi D; Villani F; Benedetti L
Epileptic Disord; 2024 Jun; 26(3):407-411. PubMed ID: 38619369
[No Abstract] [Full Text] [Related]
[Next] [New Search]
